Saturday, July 28, 2018

3:20 PM - 4:00 PM

Maritime Room 1

---

Details

Biosimilar medicines are becoming increasingly available in Australia and have the potential to provide significant savings to the health care system and improve patient care. The introduction of biosimilar medicines has widened the scope of brand substitution in Australia. With nine brands of biosimilar medicines currently approved for use in Australia, seven of which are also listed on the PBS, pharmacists will be increasingly faced with opportunities to engage consumers in discussions about biosimilar substitution. This session will help pharmacists build an awareness of the current use of biosimilar medicines in Australia and internationally and identify the potential implications of dispensing biosimilars for pharmacists in various practice settings. Learning Objectives:- • Describe biological and biosimilar medicines • Develop an awareness of the current use of biosimilar medicines in Australia and internationally • Discuss the similarities and differences between bioequivalent and biosimilar medicines • Describe the impact of biosimilars for patient care and disease management • Identify potential implications of dispensing biosimilars for pharmacists working in various practice settings. Competencies (2016) addressed: 3.1.2, 3.2.5, 3.3.1, 3.6.1. Competencies (2010) addressed: 4.1.3, 4.2.2, 4.3.3, 6.1.2, 6.2.2, 7.1.2

---

Speaker